The Cell-Based Biological Reagents market size is expected to reach $20.74 billion in 2030 at a CAGR of 8.6%, driven by growing cell and gene therapy demand.
Read More
The Cell Sheet-Based Gene Therapy market size is expected to reach $1.34 billion in 2030 at a CAGR of 14.6%, driven by increasing chronic disease prevalence.
Read More
The Bronchial Spasm market size is expected to reach $5.35 billion in 2030 at a CAGR of 7.0%, driven by increasing prevalence of respiratory diseases.
Read More
The Bioprocess Digital Twin market size is expected to reach $4.88 billion in 2030 at a CAGR of 24.6%, driven by expanding biopharmaceutical production.
Read More
The Biologics Sterile Fill-Finish Services market size is expected to reach $8.35 billion in 2030 at a CAGR of 10.7%, driven by rising biosimilar approvals.
Read More
The Biologics Active Pharmaceutical Ingredient (API) market size is expected to reach $101.84 billion in 2030 at a CAGR of 8.8%, driven by increasing personalized medicine demand.
Read More
The Bioconjugation market size is expected to reach $11.12 billion in 2030 at a CAGR of 12.7%, driven by rising targeted therapeutics demand.
Read More
The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening market size is expected to reach $3.43 billion in 2030 at a CAGR of 17.7%, driven by increasing focus on personalized medicine.
Read More
The Antibiotics Active Pharmaceutical Ingredient (API) market size is expected to reach $44.5 billion in 2030 at a CAGR of 11.1%, driven by rising prevalence of bacterial infections.
Read MoreThe Clinical Trials market size is expected to reach $176.32 billion in 2030 at a CAGR of 6.8%, driven by new drug development demand.
Read More